Our top pick for
Wave Life Sciences Ltd is a biotechnology business based in the US. Wave Life Sciences shares (WVE) are listed on the NASDAQ and all prices are listed in US Dollars. Wave Life Sciences employs 217 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$6.61 - $19.98|
|50-day moving average||$10.18|
|200-day moving average||$9.79|
|Wall St. target price||$16.57|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-5.15|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||$20.1 million|
|Gross profit TTM||$-110,867,000|
|Return on assets TTM||-34.02%|
|Return on equity TTM||-184.78%|
|Market capitalisation||$453.2 million|
TTM: trailing 12 months
There are currently 4.4 million Wave Life Sciences shares held short by investors – that's known as Wave Life Sciences's "short interest". This figure is 2.4% up from 4.3 million last month.
There are a few different ways that this level of interest in shorting Wave Life Sciences shares can be evaluated.
Wave Life Sciences's "short interest ratio" (SIR) is the quantity of Wave Life Sciences shares currently shorted divided by the average quantity of Wave Life Sciences shares traded daily (recently around 451271.26673532). Wave Life Sciences's SIR currently stands at 9.71. In other words for every 100,000 Wave Life Sciences shares traded daily on the market, roughly 9710 shares are currently held short.
However Wave Life Sciences's short interest can also be evaluated against the total number of Wave Life Sciences shares, or, against the total number of tradable Wave Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Wave Life Sciences's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Wave Life Sciences shares in existence, roughly 100 shares are currently held short) or 0.1263% of the tradable shares (for every 100,000 tradable Wave Life Sciences shares, roughly 126 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Wave Life Sciences.
Find out more about how you can short Wave Life Sciences stock.
We're not expecting Wave Life Sciences to pay a dividend over the next 12 months.
Over the last 12 months, Wave Life Sciences's shares have ranged in value from as little as $6.61 up to $19.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Wave Life Sciences's is 0.3738. This would suggest that Wave Life Sciences's shares are less volatile than average (for this exchange).
Wave Life Sciences Ltd. , a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd.
Everything we know about the TC Bancshares IPO, plus information on how to buy in.
Everything we know about the Soulgate IPO, plus information on how to buy in.
Everything we know about the Alzamend Neuro IPO, plus information on how to buy in.
Everything we know about the Singular Genomics Systems IPO, plus information on how to buy in.
Everything we know about the Golden Sun Education Group Limited IPO, plus information on how to buy in.
Everything we know about the Phillips Edison & Company IPO, plus information on how to buy in.
Everything we know about the FIGS IPO, plus information on how to buy in.
Everything we know about the DLocal Limited IPO, plus information on how to buy in.
Everything we know about the Torchy’s Tacos IPO, plus information on how to buy in.
Everything we know about the Dutch Bros Coffee IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.